Citadel Advisors »

Edesa Biotech shares owned by Citadel Advisors

Quarter-by-quarter ownership of Edesa Biotech (EDSA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Edesa Biotech

Tip: Access up to 7 years of quarterly data

All positions including Edesa Biotech held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edesa Biotech by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $34k 14k 2.44
2025-06-30 $48k 24k 2.02
2025-03-31 $41k 17k 2.44
2024-12-31 $70k 41k 1.70

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Edesa Biotech

Rubric Capital Management
Stonepine Capital Management
Velan Capital Investment Management
Nantahala Capital Management
Vanguard Group
Geode Capital Management
Commonwealth Equity Services
Renaissance Technologies
Susquehanna International
Citadel Advisors
UBS Group
Royal Bank of Canada
Tower Research Capital
Morgan Stanley
TD Waterhouse Canada

View all funds holding Edesa Biotech